TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth
miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-15...
Gespeichert in:
Veröffentlicht in: | Oncotarget 2013-11, Vol.4 (11), p.1894-1903 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1903 |
---|---|
container_issue | 11 |
container_start_page | 1894 |
container_title | Oncotarget |
container_volume | 4 |
creator | Mattiske, Sam Ho, Kristen Noll, Jacqueline E Neilsen, Paul M Callen, David F Suetani, Rachel J |
description | miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown. |
doi_str_mv | 10.18632/oncotarget.1228 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3875757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1464494909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</originalsourceid><addsrcrecordid>eNpVUU1PwzAMjRCITWN3TqhHLh35bJIL0jTxJU1CQrtHWZt2QW0zkhTEvyewMYZ9sGX7PVt-AFwiOEOiIPjG9aWL2jcmzhDG4gSMkaQyx4yR06N8BKYhvMJkjHKB5TkYYYo4RwUfg8fVfFuQzJtmaHU0IfsmbUxvy6yzLzliLIsu60xlUzeVGq-jdX2m-yqLQ-cGnzXefcTNBTirdRvMdB8nYHV_t1o85svnh6fFfJmXRBYxLykxFEpJa82kIKhGjNScp8SQAldIaF4TyLhhbG2EJpBCoquaYsFRJSiZgNsd7XZYp6tK00evW7X1ttP-Uzlt1f9Obzeqce-KCM6SJ4LrPYF3b4MJUXU2lKZtdW_cEBSiBaXpdVCmUbgbLb0LwZv6sAZB9SOB-pNAfUuQIFfH5x0Avw8nX6OZhHY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464494909</pqid></control><display><type>article</type><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free E- Journals</source><source>PubMed Central Open Access</source><creator>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</creator><creatorcontrib>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</creatorcontrib><description>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.1228</identifier><identifier>PMID: 24177167</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Animals ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cell Movement - physiology ; Female ; Gene Expression Regulation, Neoplastic ; Gene Knockdown Techniques ; Heterografts ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs - antagonists & inhibitors ; MicroRNAs - biosynthesis ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Research Paper ; Transcription Factors - biosynthesis ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Tumor Suppressor Proteins - biosynthesis ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism ; Up-Regulation</subject><ispartof>Oncotarget, 2013-11, Vol.4 (11), p.1894-1903</ispartof><rights>Copyright: © 2013 Mattiske et al. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</citedby><cites>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875757/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875757/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24177167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mattiske, Sam</creatorcontrib><creatorcontrib>Ho, Kristen</creatorcontrib><creatorcontrib>Noll, Jacqueline E</creatorcontrib><creatorcontrib>Neilsen, Paul M</creatorcontrib><creatorcontrib>Callen, David F</creatorcontrib><creatorcontrib>Suetani, Rachel J</creatorcontrib><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</description><subject>Animals</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cell Movement - physiology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Knockdown Techniques</subject><subject>Heterografts</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>MicroRNAs - antagonists & inhibitors</subject><subject>MicroRNAs - biosynthesis</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Research Paper</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Tumor Suppressor Proteins - biosynthesis</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Up-Regulation</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1PwzAMjRCITWN3TqhHLh35bJIL0jTxJU1CQrtHWZt2QW0zkhTEvyewMYZ9sGX7PVt-AFwiOEOiIPjG9aWL2jcmzhDG4gSMkaQyx4yR06N8BKYhvMJkjHKB5TkYYYo4RwUfg8fVfFuQzJtmaHU0IfsmbUxvy6yzLzliLIsu60xlUzeVGq-jdX2m-yqLQ-cGnzXefcTNBTirdRvMdB8nYHV_t1o85svnh6fFfJmXRBYxLykxFEpJa82kIKhGjNScp8SQAldIaF4TyLhhbG2EJpBCoquaYsFRJSiZgNsd7XZYp6tK00evW7X1ttP-Uzlt1f9Obzeqce-KCM6SJ4LrPYF3b4MJUXU2lKZtdW_cEBSiBaXpdVCmUbgbLb0LwZv6sAZB9SOB-pNAfUuQIFfH5x0Avw8nX6OZhHY</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Mattiske, Sam</creator><creator>Ho, Kristen</creator><creator>Noll, Jacqueline E</creator><creator>Neilsen, Paul M</creator><creator>Callen, David F</creator><creator>Suetani, Rachel J</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131101</creationdate><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><author>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cell Movement - physiology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Knockdown Techniques</topic><topic>Heterografts</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>MicroRNAs - antagonists & inhibitors</topic><topic>MicroRNAs - biosynthesis</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Research Paper</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Tumor Suppressor Proteins - biosynthesis</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Up-Regulation</topic><toplevel>online_resources</toplevel><creatorcontrib>Mattiske, Sam</creatorcontrib><creatorcontrib>Ho, Kristen</creatorcontrib><creatorcontrib>Noll, Jacqueline E</creatorcontrib><creatorcontrib>Neilsen, Paul M</creatorcontrib><creatorcontrib>Callen, David F</creatorcontrib><creatorcontrib>Suetani, Rachel J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mattiske, Sam</au><au>Ho, Kristen</au><au>Noll, Jacqueline E</au><au>Neilsen, Paul M</au><au>Callen, David F</au><au>Suetani, Rachel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2013-11-01</date><risdate>2013</risdate><volume>4</volume><issue>11</issue><spage>1894</spage><epage>1903</epage><pages>1894-1903</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>24177167</pmid><doi>10.18632/oncotarget.1228</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2013-11, Vol.4 (11), p.1894-1903 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3875757 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free E- Journals; PubMed Central Open Access |
subjects | Animals Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - pathology Cell Movement - physiology Female Gene Expression Regulation, Neoplastic Gene Knockdown Techniques Heterografts Humans Mice Mice, Inbred BALB C Mice, Nude MicroRNAs - antagonists & inhibitors MicroRNAs - biosynthesis MicroRNAs - genetics MicroRNAs - metabolism Research Paper Transcription Factors - biosynthesis Transcription Factors - genetics Transcription Factors - metabolism Tumor Suppressor Proteins - biosynthesis Tumor Suppressor Proteins - genetics Tumor Suppressor Proteins - metabolism Up-Regulation |
title | TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A23%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TAp63%20regulates%20oncogenic%20miR-155%20to%20mediate%20migration%20and%20tumour%20growth&rft.jtitle=Oncotarget&rft.au=Mattiske,%20Sam&rft.date=2013-11-01&rft.volume=4&rft.issue=11&rft.spage=1894&rft.epage=1903&rft.pages=1894-1903&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.1228&rft_dat=%3Cproquest_pubme%3E1464494909%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1464494909&rft_id=info:pmid/24177167&rfr_iscdi=true |